Does the Drug Shortage White Paper Fall Short?
FDA Law
APRIL 8, 2024
In its report, Drug Shortages: Root Causes and Potential Solutions, FDA explains that the equipment needed to produce sterile injectables is highly specialized and expensive, meaning that in a shortage situation, production capacity cannot be substantially increased without taking the time and expense of procuring and qualifying new equipment.
59 
Let's personalize your content